References

Author	McGrath (2007)
Title	Antiviral efficacy and emergent PI substitutions in treatment-naive subjects receiving atazanavir +/- ritonavir-based HAART in subtype b and non-type b HIV-1 infection.
Citation	IHDRW 2007

Clinical PR Isolates

Subject	Isolate	PIs	Wks	PIMajor	PIMinor	Common	Unusual
1	DMG_1	None				T12S, I15V, L19I, M36I, R41K, L63PS, H69K, I93L
	DMG_1a	RTV, ATV	48		N83ND	T12S, I15V, L19I, M36I, R41K, L63PS, H69K, I93L
10	DMG_10	None				L10LI, I13IV, L33V, N37X, R41RK, I62V, L63APS, I64V, C67CY, H69HQ
	DMG_10a	ATV	48			L10LI, I13IV, L33V, N37X, R41RK, I62V, L63APS, I64V, C67CY, H69HQ
2	DMG_2	None				T12S, I15V, L19I, K20R, E35D, M36I, R41K, H69K, L89M, I93L
	DMG_2a	RTV, ATV	48			T12S, I15V, L19I, K20R, E35D, M36I, R41K, H69K, L89M, I93L
3	DMG_3	None				E35D, M36I, R57K, I62V, L63P, I64IL, A71AV, I72IV, V77VI, P79PAS, I93IL
	DMG_3a	ATV	48			E35D, M36I, R57K, I62V, L63P, I64IL, A71AV, I72IV, V77VI, P79PAS, I93IL
4	DMG_4	None				L10LI, P39PS, L63P, V77I, I93L
	DMG_4a	ATV	48	I50IL		L10LI, E34EQ, P39PS, L63P, V77I, I93L
5	DMG_5	None				L10I, T12TK, I13IV, N37X, L63P, I64IV, I93L
	DMG_5a	ATV	48	I50IL	G73GS	L10I, T12TK, I13IV, N37X, L63P, I64IV, A71AV, T74TA, I93L
6	DMG_6	None				T12S, I15V, L19I, M36IT, R41K, K43KR, L63P, H69K, L89LM, I93L
	DMG_6a	ATV	48			T12S, I15V, L19I, M36IT, R41K, K43KR, L63P, H69K, L89LM, I93L
7	DMG_7	None				L10I, I13V, G16GE, L19T, K20R, M36I, R41K, L63AITV, I64IM, E65D, H69K, L89M, I93L
	DMG_7a	ATV	48			L10I, I13V, G16GE, L19T, K20R, M36I, R41K, L63AITV, I64IM, E65D, H69K, T74TA, L89M, I93L
8	DMG_8	None				L10I, I15V, G16E, E35D, L63H, V77VI, L89M
	DMG_8a	ATV	48	I50L, N88NS	L33LF	L10I, I15V, G16E, K20KIT, E35D, M36MV, L63H, A71AV, V77VI, L89M	L23LP
9	DMG_9	None			V11IT	L10I, E35D, Q61E, I62V, L63P, I64L, A71V, I72T, V77I, P79AS, I93L
	DMG_9a	ATV	48		V11IT	L10I, E35D, Q61E, I62V, L63P, I64L, A71V, I72T, V77I, P79AS, I93L